Cargando…
Preparation of a First (18)F-Labeled Agonist for M(1) Muscarinic Acetylcholine Receptors
M(1) muscarinic acetylcholine receptors (mAChRs) are abundant in postsynaptic nerve terminals of all forebrain regions and have been implicated in the cognitive decline associated with Alzheimer’s disease and other CNS pathologies. Consequently, major efforts have been spent in the development of su...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355535/ https://www.ncbi.nlm.nih.gov/pubmed/32585815 http://dx.doi.org/10.3390/molecules25122880 |
_version_ | 1783558298284326912 |
---|---|
author | Zlatopolskiy, Boris D. Neumaier, Felix Rüngeler, Till Drewes, Birte Kolks, Niklas Neumaier, Bernd |
author_facet | Zlatopolskiy, Boris D. Neumaier, Felix Rüngeler, Till Drewes, Birte Kolks, Niklas Neumaier, Bernd |
author_sort | Zlatopolskiy, Boris D. |
collection | PubMed |
description | M(1) muscarinic acetylcholine receptors (mAChRs) are abundant in postsynaptic nerve terminals of all forebrain regions and have been implicated in the cognitive decline associated with Alzheimer’s disease and other CNS pathologies. Consequently, major efforts have been spent in the development of subtype-selective positron emission tomography (PET) tracers for mAChRs resulting in the development of several (11)C-labeled probes. However, protocols for the preparation of (18)F-labeled mAChR-ligands have not been published so far. Here, we describe a straightforward procedure for the preparation of an (18)F-labeled M(1) mAChR agonist and its corresponding pinacol boronate radiolabeling precursor and the non-radioactive reference compound. The target compounds were prepared from commercially available aryl fluorides and Boc protected 4-aminopiperidine using a convergent reaction protocol. The radiolabeling precursor was prepared by a modification of the Miyaura reaction and labeled via the alcohol-enhanced Cu-mediated radiofluorination. The developed procedure afforded the radiotracer in a non-decay-corrected radiochemical yield of 17 ± 3% (n = 3) and in excellent radiochemical purity (>99%) on a preparative scale. Taken together, we developed a straightforward protocol for the preparation of an (18)F-labeled M(1) mAChR agonist that is amenable for automation and thus provides an important step towards the routine production of a (18)F-labeled M(1) selective PET tracer for experimental and diagnostic applications. |
format | Online Article Text |
id | pubmed-7355535 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-73555352020-07-23 Preparation of a First (18)F-Labeled Agonist for M(1) Muscarinic Acetylcholine Receptors Zlatopolskiy, Boris D. Neumaier, Felix Rüngeler, Till Drewes, Birte Kolks, Niklas Neumaier, Bernd Molecules Article M(1) muscarinic acetylcholine receptors (mAChRs) are abundant in postsynaptic nerve terminals of all forebrain regions and have been implicated in the cognitive decline associated with Alzheimer’s disease and other CNS pathologies. Consequently, major efforts have been spent in the development of subtype-selective positron emission tomography (PET) tracers for mAChRs resulting in the development of several (11)C-labeled probes. However, protocols for the preparation of (18)F-labeled mAChR-ligands have not been published so far. Here, we describe a straightforward procedure for the preparation of an (18)F-labeled M(1) mAChR agonist and its corresponding pinacol boronate radiolabeling precursor and the non-radioactive reference compound. The target compounds were prepared from commercially available aryl fluorides and Boc protected 4-aminopiperidine using a convergent reaction protocol. The radiolabeling precursor was prepared by a modification of the Miyaura reaction and labeled via the alcohol-enhanced Cu-mediated radiofluorination. The developed procedure afforded the radiotracer in a non-decay-corrected radiochemical yield of 17 ± 3% (n = 3) and in excellent radiochemical purity (>99%) on a preparative scale. Taken together, we developed a straightforward protocol for the preparation of an (18)F-labeled M(1) mAChR agonist that is amenable for automation and thus provides an important step towards the routine production of a (18)F-labeled M(1) selective PET tracer for experimental and diagnostic applications. MDPI 2020-06-23 /pmc/articles/PMC7355535/ /pubmed/32585815 http://dx.doi.org/10.3390/molecules25122880 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Zlatopolskiy, Boris D. Neumaier, Felix Rüngeler, Till Drewes, Birte Kolks, Niklas Neumaier, Bernd Preparation of a First (18)F-Labeled Agonist for M(1) Muscarinic Acetylcholine Receptors |
title | Preparation of a First (18)F-Labeled Agonist for M(1) Muscarinic Acetylcholine Receptors |
title_full | Preparation of a First (18)F-Labeled Agonist for M(1) Muscarinic Acetylcholine Receptors |
title_fullStr | Preparation of a First (18)F-Labeled Agonist for M(1) Muscarinic Acetylcholine Receptors |
title_full_unstemmed | Preparation of a First (18)F-Labeled Agonist for M(1) Muscarinic Acetylcholine Receptors |
title_short | Preparation of a First (18)F-Labeled Agonist for M(1) Muscarinic Acetylcholine Receptors |
title_sort | preparation of a first (18)f-labeled agonist for m(1) muscarinic acetylcholine receptors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355535/ https://www.ncbi.nlm.nih.gov/pubmed/32585815 http://dx.doi.org/10.3390/molecules25122880 |
work_keys_str_mv | AT zlatopolskiyborisd preparationofafirst18flabeledagonistform1muscarinicacetylcholinereceptors AT neumaierfelix preparationofafirst18flabeledagonistform1muscarinicacetylcholinereceptors AT rungelertill preparationofafirst18flabeledagonistform1muscarinicacetylcholinereceptors AT drewesbirte preparationofafirst18flabeledagonistform1muscarinicacetylcholinereceptors AT kolksniklas preparationofafirst18flabeledagonistform1muscarinicacetylcholinereceptors AT neumaierbernd preparationofafirst18flabeledagonistform1muscarinicacetylcholinereceptors |